GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entheon Biomedical Corp (XCNQ:ENBI) » Definitions » Price-to-Free-Cash-Flow

Entheon Biomedical (XCNQ:ENBI) Price-to-Free-Cash-Flow : N/A (As of May. 15, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Entheon Biomedical Price-to-Free-Cash-Flow?

As of today (2024-05-15), Entheon Biomedical's share price is C$0.15. Entheon Biomedical's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Feb. 2024 was C$-0.05. Hence, Entheon Biomedical's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Entheon Biomedical's Price-to-Free-Cash-Flow or its related term are showing as below:

XCNQ:ENBI's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 32.23
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Entheon Biomedical's Free Cash Flow per Share for the three months ended in Feb. 2024 was C$-0.02. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was C$-0.05.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 41.80% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 33.90% per year.

During the past 7 years, Entheon Biomedical's highest 3-Year average Free Cash Flow per Share Growth Rate was 41.80% per year. The lowest was -295.80% per year. And the median was 8.50% per year.


Entheon Biomedical Price-to-Free-Cash-Flow Historical Data

The historical data trend for Entheon Biomedical's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entheon Biomedical Price-to-Free-Cash-Flow Chart

Entheon Biomedical Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Nov21 Nov22 Nov23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial - - - - -

Entheon Biomedical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Entheon Biomedical's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Entheon Biomedical's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Entheon Biomedical's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Entheon Biomedical's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Entheon Biomedical's Price-to-Free-Cash-Flow falls into.



Entheon Biomedical Price-to-Free-Cash-Flow Calculation

Entheon Biomedical's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.15/-0.045
=N/A

Entheon Biomedical's Share Price of today is C$0.15.
Entheon Biomedical's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.05.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Entheon Biomedical  (XCNQ:ENBI) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Entheon Biomedical Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Entheon Biomedical's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Entheon Biomedical (XCNQ:ENBI) Business Description

Traded in Other Exchanges
Address
999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5
Entheon Biomedical Corp is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (DMT Products) for the purposes of treating addiction and substance use disorders. Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics, and licensed psychiatrists in the United States, certain countries in the European Union, and throughout Canada.

Entheon Biomedical (XCNQ:ENBI) Headlines

No Headlines